Skip to content
Search

Latest Stories

Health Foundation’s response to King's Speech: No wealth without good health

Health Foundation’s response to King's Speech: No wealth without good health

Responding to the King’s Speech, Dame Jennifer Dixon, CEO of the Health Foundation, emphasises that getting the NHS back on its feet will need “long-term investment and reform”  

“Securing economic growth will be a fundamental mission,” King Charles III stated in his address to both Houses of Parliament on Wednesday, July 17.


The 2024 King’s Speech marked the opening of the first session of the new parliament since the general election.

“My Government will seek a new partnership with both business and working people and help the country move on from the recent cost of living challenges by prioritising wealth creation for all communities,” the King said.

However, the Health Foundation, an independent charitable organisation, has emphasised the importance of improving the nation’s health to achieve economic growth.

In response to the King’s Speech, Dame Jennifer Dixon, chief executive of the Health Foundation, said: “Economic growth and national renewal are at the centre of today’s King’s Speech, but those aims can only be achieved by building a healthier UK.”

"Without good health, there will be no wealth," she added, emphasising that a cross-government approach to improving the nation’s health must be central to government policy to achieve its goals.

Jennifer welcomed the proposed legislation to restrict smoking and limit advertising and availability of harmful products to children, calling these “significant steps forward.”

“We hope this signals a much bolder approach to improving public health,” she said.

Jennifer also highlighted the importance of addressing the wider social and environmental factors that influence people’s health. Therefore, she welcomed the new government's commitment to introducing legislation to increase the provision of high-quality homes, improve the rights of renters and strengthen employment rights.

The King also announced that his government will improve the National Health Service (NHS) as a service for all.

“It will seek to reduce the waiting times, focus on prevention and improve mental health provision for young people,” he said.

However, Jennifer emphasised that getting the NHS back on its feet will need “long-term investment and reform.”

“We welcome the commitment to tackling long waits for care and the focus on prevention. There are no quick fixes, but the NHS can recover with the right blend of policy change, innovation and investment.”

The charity also welcomed the long-overdue reform of the Mental Health Act.

The King stated that mental health would be given the same attention and focus as physical health. He confirmed the Mental Health Bill, which aims to modernise the Mental Health Act to ensure it is suitable for the twenty-first century.

The Labour government is also committed to introducing a Tobacco and Vapes Bill to “progressively increase the age at which people can buy cigarettes and impose limits on the sale and marketing of vapes.”

Jennifer reiterated: “A thriving economy can only be built on the foundations of a healthy population, renewed focus on tackling health inequalities and a strong health service.”

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less